Intratumoral Injection Of Alpha-Gal Glycosphingolipids

Clinical trial NCT00668512 · COMPLETED

Trial details

NCT number: NCT00668512
Sponsor: University of Massachusetts, Worcester
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2007-03-01
Primary completion: 2014-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.